IXICO (LON:IXI) Stock Price Down 12.2% – Should You Sell?

IXICO plc (LON:IXI) was down 12.2% during trading on Thursday . The stock traded as low as GBX 8.56 and last traded at GBX 9. Approximately 2,252,712 shares traded hands during trading, an increase of 1,835% from the average daily volume of 116,391 shares. The stock had previously closed at GBX 10.25.

IXICO Price Performance

The company has a debt-to-equity ratio of 3.32, a quick ratio of 4.90 and a current ratio of 2.85. The stock’s fifty day moving average price is GBX 11.22 and its 200-day moving average price is GBX 11.60. The firm has a market cap of £8.34 million, a PE ratio of -4.86, a P/E/G ratio of -0.38 and a beta of 0.86.

IXICO (LON:IXI) last released its quarterly earnings data on Tuesday, December 9th. The company reported GBX (1.85) EPS for the quarter. IXICO had a negative return on equity of 19.14% and a negative net margin of 31.10%. As a group, equities analysts forecast that IXICO plc will post -289.3584879 EPS for the current fiscal year.

About IXICO

IXICO is a global leader in neuroscience imaging and biomarker analytics, using its proprietary AI-driven platform to help advance the treatment of neurological disorders and reduce the uncertainties associated with drug discovery, development and monitoring.

By unlocking valuable insights into drug safety and efficacy, IXICO has built a global reputation and 20-year track record as an end-to-end Imaging Contract Research Organisation (iCRO) managing and analysing neurological clinical trials.